Trial drug can significantly block early stages of COVID-19 in engineered human tissues
by Press Release from Outbreak News Today on (#51QY6)
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel coronavirus that, as of April 2, has ["]
The post Trial drug can significantly block early stages of COVID-19 in engineered human tissues appeared first on Outbreak News Today.